Adriana E. Manzi

With over 25 years of experience in biomolecules R&D, since 2006 Dr. Manzi’s consulting work has spanned the areas of recombinant, fusion and transgenic proteins, dendritic cell vaccines, biosimilars, analytical method development and validation, CMC, selection and management of CMOs /CROs, due diligence and writing of expert opinions. As a consultant, Adriana has led the CMC efforts for several virtual companies through their first successful IND filing, interacted with regulators in the US and EU, advised international investors, provided technical opinions to law firms and participated in global due diligence efforts.

Previously, Dr. Manzi was Sr. Director of Research for Baxter Healthcare Corp., Director of Analytical Development / Quality Control at Nextran Inc., and Cytel Corporation as well as Director of the Glycobiology Core Facility at the University of California San Diego (UCSD).

The therapeutic areas in which she has worked include: oncology, renal disease, xenotransplantation, orphan diseases, heart disease and ophthalmology (AMD).

Dr.Manzi received her B.S. (Chemistry) / M.S. (Industrial Chemistry and Food Sciences), and her PhD in Organic Chemistry (suma cum laude) from the University of Buenos Aires, Argentina. Dr. Manzi completed her Postdoctoral Research in biochemistry and glycobiology at the University of California San Diego Cancer Center where she became an Assistant Professor. She is an expert on structural analysis of complex biomolecules, including glycosylation, and has taught glycobiology for UCSD, SDSU and IBC as well as the FDA and the National Institute of Standards and Technologies (NIST). Dr. Manzi has published 28 original research articles and 20 book chapters. She is a member of the Advisory Board of Bioprocess International and Laureate Biopharmaceuticals, Inc. and active in professional organizations.